Evotec SE (EVO) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 31.13% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 291.15% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | -11.88% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -31.43% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 20.00% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 6,792.11% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 712.82% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 96.82% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 74.54% |
| Dec 31, 2025 | -169.69% |
| Sep 30, 2025 | 19.66% |
| Jun 30, 2025 | 42.04% |
| Mar 31, 2025 | 56.21% |
| Dec 31, 2024 | 92.92% |
| Jun 30, 2024 | 76.31% |
| Mar 31, 2024 | -194.47% |
| Dec 31, 2023 | -23.85% |
| Jun 30, 2023 | -290.52% |
| Mar 31, 2023 | 196.05% |
| Dec 31, 2022 | 26.12% |
| Sep 30, 2022 | 152.46% |
| Jun 30, 2022 | -146.92% |
| Mar 31, 2022 | -109,924.74% |
| Jun 30, 2010 | -392.29% |
| Mar 31, 2010 | -391.93% |